Serological Response to Treatment of Syphilis According to Disease Stage and HIV Status
Open Access
- 5 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (12) , 1615-1622
Abstract
Background. Serology is the mainstay for syphilis diagnosis and treatment monitoring. We investigated serological response to treatment of syphilis according to disease stage and HIV status. Methods. A retrospective cohort study of 264 patients with syphilis was conducted, including 90 primary, 133 secondary, 33 latent, and 8 tertiary syphilis cases. Response to treatment as measured by the Venereal Disease Research Laboratory (VDRL) test and a specific IgM (immunoglobulin M) capture enzyme-linked immunosorbent assay (ELISA; Pathozyme-IgM) was assessed by Cox regression analysis. Results. Forty-two percent of primary syphilis patients had a negative VDRL test at their diagnosis. Three months after treatment, 85%–100% of primary syphilis patients had reached the VDRL endpoint, compared with 76%–89% of patients with secondary syphilis and 44%–79% with latent syphilis. In the overall multivariate Cox regression analysis, serological response to treatment was not influenced by human immunodeficiency virus (HIV) infection and reinfection. However, within primary syphilis, HIV patients with a CD4 count of P = .012). Compared with primary syphilis, secondary and latent syphilis showed a slower serological response of VDRL (P = .092 and P < .001) and Pathozyme-IgM tests (P < .001 and P = .012). Conclusions. The VDRL should not be recommended as a screening test owing to lack of sensitivity. The syphilis disease stage significantly influences treatment response whereas HIV coinfection only within primary syphilis has an impact. VDRL test titers should decline at least 4-fold within 3–6 months after therapy for primary or secondary syphilis, and within 12–24 months for latent syphilis. IgM ELISA might be a supplement for diagnosis and treatment monitoring.Keywords
This publication has 30 references indexed in Scilit:
- NovelTreponema pallidumSerologic Tests: A Paradigm Shift in Syphilis Screening for the 21st CenturyClinical Infectious Diseases, 2010
- Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort StudyAIDS, 2010
- Factors Determining Serologic Response to Treatment in Patients with SyphilisClinical Infectious Diseases, 2009
- Clinical and Serologic Baseline and Follow-Up Features of Syphilis According to HIV Status in the Post-HAART EraMedicine, 2009
- Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinicsSexually Transmitted Infections, 2006
- Syphilis Treatment and HIV Infection in a Population-Based Study of Persons at High Risk for Sexually Transmitted Disease/HIV Infection in Lima, PeruSexually Transmitted Diseases, 2006
- Recent trends in the epidemiology of sexually transmitted infections in the European UnionSexually Transmitted Infections, 2004
- Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individualsSexually Transmitted Infections, 2004
- Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women.Sexually Transmitted Infections, 1995
- SHORT COMMUNICATIONAIDS, 1991